ArticleEJHaem2025

Risk adapted therapy for newly diagnosed multiple myeloma delivered through local cytogenetic laboratories in a National Clinical Trial: UKMRA RADAR study.

Dipal Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.